The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

The recall, according to a news release published Wednesday, involves Northwest Naturals' Feline Turkey Recipe raw frozen pet ...

Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly ...

In a new study, researchers examined the health effects people experienced when they returned to still-standing homes after ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

According to the NYPD, a 58-year-old cab driver suffered a medical episode when he drove onto the sidewalk at West 34th Street and Sixth Avenue. A man accused of attempting to assassinate ...

Taxi jumps curb, slams into Christmas Day crowd outside Manhattan Macy’s on W. 34th St. A taxi cab jumped the curb and slammed into six pedestrians walking near Macy's on W. 34th St. and Sixth ...

The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...